US Patent Issued to LIMMATECH BIOLOGICS on July 28 for "Glycoengineering using Leishmania cells" (Swiss Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,472, issued on July 28, was assigned to LIMMATECH BIOLOGICS AG (Schlieren, Switzerland).

"Glycoengineering using Leishmania cells" was invented by Manuela Mally (Schlieren, Switzerland), Amirreza Faridmoayer (Schlieren, Switzerland), Rainer Follador (Schlieren, Switzerland) and Anke Judith Harsman (Schlieren, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to Leishmania cells genetically engineered such that the formation of an O-linked GlcNAc on a polypeptide in the Leishmania cell is reduced or eliminated. The formation of the O-linked GlcNAc may be catalyzed in the Leishmania cell prior to said genetic e...